Alpha Profiles · Company Profile

Biohaven Ltd.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/biohaven-ltd

Entity: Public listing published
Primary listing: NYSE: BHVN
Verification: Partially verified
Last reviewed: 2026-10-03T04:45:51.967317+00:00

Overview

Alpha's canonical identity and public leadership record for Biohaven Ltd..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

Bradley T. Sheares, Ph.D.

Chief Scientific Officer

State: confirmed
Effective: From Mar 13, 2026
Confidence: 94%
Evidence: BHVN DEF 14A executive officersMar 13, 2026

Bruce Car, Ph.D.

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: BHVN executive roster sourceMay 3, 2026

Kimberly Gentile

Senior Vice President of Clinical Operations

State: confirmed
Effective: From Mar 13, 2026
Confidence: 94%
Evidence: BHVN DEF 14A executive officersMar 13, 2026

Matthew Buten

Chief Financial Officer

State: confirmed
Effective: From Mar 13, 2026
Confidence: 94%
Evidence: BHVN DEF 14A executive officersMar 13, 2026

Vlad Coric, M.D.

Chief Executive Officer and Chairman

State: confirmed
Effective: From Mar 13, 2026
Confidence: 94%
Evidence: BHVN DEF 14A executive officersMar 13, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 3, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.